Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Retained Earnings (Deficit)
Total
Balances at Dec. 31, 2019 $ 37 $ 60,742 $ (7,970) $ 52,809
Balances (in Shares) at Dec. 31, 2019 36,876      
Common stock issued upon warrant exercise 510 510
Common stock issued upon warrant exercise (in Shares) 191      
Common stock issued upon cashless warrant exercise
Common stock issued upon cashless warrant exercise (in Shares) 19      
Common stock issued upon cashless exercise of options
Common stock issued upon cashless exercise of options (in Shares) 280      
Common stock issued in connection with business combinations   1,102   1,102
Common stock issued in connection with business combinations (in Shares) 250      
Common stock issued for assets   101   101
Common stock issued for assets (in Shares) 24      
Common stock issued for services
Common stock issued for services (in Shares) 50      
Common stock issued for share based compensation $ 1 1,760   1,761
Common stock issued for share based compensation (in Shares) 519      
Share based compensation   2,209   2,209
Net income/loss     (2,094) (2,094)
Balances at Mar. 31, 2020 $ 38 66,424 (10,064) 56,398
Balances (in Shares) at Mar. 31, 2020 38,209      
Balances at Dec. 31, 2020 $ 57 319,582 (2,642) 316,997
Balances (in Shares) at Dec. 31, 2020 57,151      
Common stock issued upon warrant exercise 111 111
Common stock issued upon warrant exercise (in Shares) 40      
Common stock issued upon cashless warrant exercise $ 1 (1)    
Common stock issued upon cashless warrant exercise (in Shares) 535      
Common stock issued upon exercise of options 2 $ 2
Common stock issued upon exercise of options (in Shares) 1     6
Common stock issued upon cashless exercise of options
Common stock issued upon cashless exercise of options (in Shares) 5      
Common stock issued in connection with business combinations   29,249   29,249
Common stock issued in connection with business combinations (in Shares) 548      
Common stock issued for share based compensation (in Shares) 300      
Common stock redeemed in litigation settlement
Common stock redeemed in litigation settlement (in Shares) (90)      
Common stock redemption   (3,954)   (3,954)
Common stock redemption (in Shares) (96)      
Share based compensation   1,187   1,187
Share based compensation (in Shares)      
Net income/loss     6,147 6,147
Balances at Mar. 31, 2021 $ 58 $ 346,176 $ 3,505 $ 349,739
Balances (in Shares) at Mar. 31, 2021 58,394